The Amyloidosis Channel is supported with funding from Prothena (Silver).
The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2016 | Renal complications in multiple myeloma – characteristics and treatment
Nelson Leung, MD from the Mayo Clinic, Rochester, MN gives an overview of the common kidney problems in multiple myeloma (MM). The proteins produced by the myeloma cells are toxic to the kidney in various ways. Prof. Leung discuses light chain cast nephropathy (LCCN), which is the most common complication and is a myeloma defining event, as well as immunoglobulin light chain (AL) amyloidosis, monoclonal immunoglobulin deposition disease (MIDD) and light chain proximal tubulopathy (LCPT) with or without Fanconi syndrome.
Recorded at the 2016 World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France.
